HV-LCI: Multiple Breath Nitrogen Washout in Healthy Volunteers

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Recruiting
CT.gov ID
NCT03447418
Collaborator
(none)
191
1
1
35.8
5.3

Study Details

Study Description

Brief Summary

This study is designed to establish reference values of multiple breath nitrogen washout indexes in an healthy population of volunteers (from childhood to adulthood)

Condition or Disease Intervention/Treatment Phase
  • Procedure: Multiple breath nitrogen washout
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
191 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Multiple Breath Nitrogen Washout in Healthy Volunteers
Actual Study Start Date :
Jul 6, 2018
Anticipated Primary Completion Date :
Jul 1, 2021
Anticipated Study Completion Date :
Jul 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Other: no treatment, open label

Procedure: Multiple breath nitrogen washout
Lung Clearance Index (LCI) will be performed in healthy volunteers with a multiple breath nitrogen washout device.

Outcome Measures

Primary Outcome Measures

  1. Lung Clearance Index 2.5% (LCI 2.5%) Value [hour 1]

    Multiple breath washout is a pulmonary function test that does not require patients' cooperation. It studies the number of lung volumes (turn-over) to clear a gaz such as nitrogen form the lungs. LCI 2,5 is most frequently reported outcome measure. It corresponds to the sum of the total expired lung volumes needed to decrease the initial gaz concretion to its 1/40th, divided by functional residual capacity. LCI can be measured in infant, preschoolers and thereafter. In order to obtain reproducible tests, three acceptable maneuvers are needed.

Secondary Outcome Measures

  1. Lung Clearance Index 5% (LCI 5%) Value [hour 1]

  2. Moment ratio M1/M0 Value [up to 1 hour]

  3. Moment ratio M0/M2 Value [up to 1 hour]

  4. Sacin value [hour 1]

    assessment of distal areas function

  5. Scond value [hour 1]

    assessment of conductive areas function

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Informed consent by participant, parent, or legal guardian

  • Healthy subjects with a social insurance

Exclusion Criteria:
  • History of a lung chronic disease

  • Premature birth (<37th weeks of amenorrhea)

  • Acute lower respiratory viral infection within 3 weeks before Multiple Breath washout

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Femme Mère Enfant Bron France

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT03447418
Other Study ID Numbers:
  • 69HCL18_0064
First Posted:
Feb 27, 2018
Last Update Posted:
Jan 27, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospices Civils de Lyon

Study Results

No Results Posted as of Jan 27, 2021